BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17060688)

  • 1. Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents.
    Ahn EH; Chang CC; Schroeder JJ
    Exp Biol Med (Maywood); 2006 Nov; 231(10):1664-72. PubMed ID: 17060688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of chemotherapeutic and cancer-protective properties of sphingosine and C2-ceramide in a human breast stem cell derived carcinogenesis model.
    Ahn EH; Yang H; Hsieh CY; Sun W; Chang CC; Schroeder JJ
    Int J Oncol; 2019 Feb; 54(2):655-664. PubMed ID: 30483770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells.
    Ahn EH; Schroeder JJ
    Exp Biol Med (Maywood); 2002 May; 227(5):345-53. PubMed ID: 11976405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.
    Ahn EH; Schroeder JJ
    Anticancer Res; 2010 Jul; 30(7):2881-4. PubMed ID: 20683027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
    Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
    Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
    Sosnowski J; Stetter-Neel C; Cole D; Durham JP; Mawhinney MG
    J Urol; 1997 Jul; 158(1):269-74. PubMed ID: 9186373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of phosphatidate phosphatase activity from the yeast Saccharomyces cerevisiae by sphingoid bases.
    Wu WI; Lin YP; Wang E; Merrill AH; Carman GM
    J Biol Chem; 1993 Jul; 268(19):13830-7. PubMed ID: 8314751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingoid bases as possible diagnostic parameters.
    Ribar S; Mesaric M; Sedic M
    Croat Med J; 2003 Apr; 44(2):165-70. PubMed ID: 12698507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphinganine causes early activation of JNK and p38 MAPK and inhibition of AKT activation in HT-29 human colon cancer cells.
    Ahn EH; Schroeder JJ
    Anticancer Res; 2006; 26(1A):121-7. PubMed ID: 16475687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type C Niemann-Pick disease: a murine model of the lysosomal cholesterol lipidosis accumulates sphingosine and sphinganine in liver.
    Goldin E; Roff CF; Miller SP; Rodriguez-Lafrasse C; Vanier MT; Brady RO; Pentchev PG
    Biochim Biophys Acta; 1992 Aug; 1127(3):303-11. PubMed ID: 1324734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of endogenous free sphingoid bases in cells induced by changing medium conditions.
    Lavie Y; Blusztajn JK; Liscovitch M
    Biochim Biophys Acta; 1994 Feb; 1220(3):323-8. PubMed ID: 8305506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines.
    Kang KS; Morita I; Cruz A; Jeon YJ; Trosko JE; Chang CC
    Carcinogenesis; 1997 Feb; 18(2):251-7. PubMed ID: 9054615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingoid Base-Upregulated Caspase-14 Expression Involves MAPK.
    Nagahara Y; Kawakami K; Sikandan A; Yagi D; Nishikawa R; Shinomiya T
    Biol Pharm Bull; 2018; 41(5):743-748. PubMed ID: 29709911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship of short-chain sphingoid bases as inhibitors of sphingosine kinase.
    De Jonghe S; Van Overmeire I; Poulton S; Hendrix C; Busson R; Van Calenbergh S; De Keukeleire D; Spiegel S; Herdewijn P
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3175-80. PubMed ID: 10560747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumonisin B1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine.
    Wang E; Riley RT; Meredith FI; Merrill AH
    J Nutr; 1999 Jan; 129(1):214-20. PubMed ID: 9915902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.
    He Q; Riley RT; Sharma RP
    Toxicol Appl Pharmacol; 2001 Jul; 174(1):69-77. PubMed ID: 11437650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sphingoid bases on the sphingolipidome in early keratinocyte differentiation.
    Sigruener A; Tarabin V; Paragh G; Liebisch G; Koehler T; Farwick M; Schmitz G
    Exp Dermatol; 2013 Oct; 22(10):677-9. PubMed ID: 24079743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells.
    Johnson CR; Chun J; Bittman R; Jarvis WD
    J Pharmacol Exp Ther; 2004 May; 309(2):452-61. PubMed ID: 14724218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of long-chain (sphingoid) bases on the monocytic differentiation of human leukemia (HL-60) cells induced by phorbol esters, 1 alpha, 25-dihydroxyvitamin D3, or ganglioside GM3.
    Stevens VL; Winton EF; Smith EE; Owens NE; Kinkade JM; Merrill AH
    Cancer Res; 1989 Jun; 49(12):3229-34. PubMed ID: 2720676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free sphingoid bases in tissues from patients with type C Niemann-Pick disease and other lysosomal storage disorders.
    Rodriguez-Lafrasse C; Rousson R; Pentchev PG; Louisot P; Vanier MT
    Biochim Biophys Acta; 1994 May; 1226(2):138-44. PubMed ID: 8204660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.